Hear from experts from Kilpatrick Townsend. Learn the latest about AI’s New Role in Developing Patents, Attracting Investment, and Conducting Clinical Trials.
Artificial Intelligence (AI) is revolutionizing various aspects of industries, including its role in developing patents, attracting investment, and conducting clinical trials.
The evolving landscape of intellectual property rights in the realm of AI technology reflects the profound impact of artificial intelligence on innovation. With AI systems increasingly contributing to the creation of novel inventions, the issue of inventorship has become notably complex. To address this complexity, the United States Patent Office (USPTO) has provided clear guidance and frameworks to evaluate inventorship in AI-assisted inventions. By doing so, the USPTO’s aim is to ensure that human inventors receive proper recognition and protection for their contributions.
We will give an update on recent trends in venture capital investment in artificial intelligence and machine learning companies. Looking at different AI & ML industry segments, we compare them to investment activities in the overall venture capital markets. We will take a glimpse at typical deal venture terms for early stage and later stage investments. Still being a nascent technology, certain existing and developing subsegments of AI & ML have a higher potential of outperforming other industries in 2024 and beyond.
In the field of clinical trials, AI is streamlining processes by automating tasks such as patient recruitment, data analysis, and drug discovery. By harnessing the power of machine learning algorithms, researchers can identify suitable candidates for clinical trials more efficiently, analyze complex datasets to uncover valuable insights, and even predict patient responses to treatments. This not only expedites the drug development process but also improves patient outcomes by facilitating the discovery of more effective treatments.
Overall, AI's new role in patent development, investment attraction, and clinical trials promises to drive innovation, improve decision-making, and ultimately transform the landscape of various industries.
Event Details
Wednesday, April 17, 2024
Dublin Technology Center
6200 Village Parkway, Dublin, California 94568
5:45 p.m. - 6:30 p.m. (Program)
6:30 p.m. - 6:45p.m. (Q&A)
Disclaimer
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.
